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The e pide rmis, in particular epidermal cytokines, 
have been shown to modulate a number of inflammatory 
and cellular immune responses. In this study we have 
demonstrated that the partially purified epidermal cy-
tokine, epidermal thy mocyte activating factor (ETAF) , 
a polypeptide r e leased by keratinocytes, is a pote nt T-
cell chemoattractant. Compared to its ability to augment 
lectin-stimulated thymocyte proliferation, ET AF is 
much more active as aT-cell chemoattractant. The re-
sults of this study give further support to the role of 
local e pidermal factors in immune reactivity . This find-
ing may have particular relevance to pathologic states 
characterized by T-cell infiltration in the skin, such as 
c utaneous T-celllymphoma. 
I t has rece n t ly beco me ev ide nt t hat s kin ca n play a n act ive 
ro le in immune- mediated events ( rev iewed in [1 ]). In additio n 
to t he a nti ge n -presen t ing capabi li ties of L a nge rhans ce ll s, ker -
atinocytes produce a cytoki ne with inter leukin 1 (IL-1)-li ke 
activ ity, termed ep ide rma l ce ll -derived t hymocyte activating 
fact.o r (ETAF) , which ca n a ugme n t in te rl eukin 2 production by 
T ce ll s [2,3, reviewed in 4) . Alt hough t he ro le of t his ep ide rmal 
cytokin e in cuta neous disease is unknown , it is likely t hat 
ETAF functio ns in a m a nne r s imil a r to that of IL-l in various 
immune processes t hat are ge ne rated in t he skin. In this rega rd, 
a numbe r o f immunologicall y mediated diso rde rs a nd neop lastic 
diso rde rs affect ing t he s kin a re c ha racte ri zed by T-cell infil t ra-
t io n. ETAF, like IL-l , can inc rease the numbe r ofT cells loca lly 
by t rigge ring a local proliferatio n of t hese cells. It is not known 
whethe r ETAF ca n a lso play a role in t he migration of T cell s 
to cuta neous s ites. 
R ecent studies have suggested t hat so lu b le factors may a lso 
p lay a ro le in T -lym phocyte che motax is . Ward et a l [5 ] d e-
sc ribed a T -ce ll c he motacti c factor produced by co ncanavali n 
A-st imulated rat spl e nic lymp hocytes. T h is obse rvation has 
been co nfirmed by E l-N aggar , VanEpps, a nd Williams [6] who 
found a ly mp ho kine in mixed lymp hocyt.e reaction s upernatant 
with s ignifi ca n t c he motactic activity for T ce lls. C ruiks ha nk 
a nd Cen te r a lso desc ribed a lympho kin e o f 56,000 daltons that 
preferentia lly att racted lymp hocytes ove r m~nocytes a nd neu -
t rop hils [7]. Va n Epps et a l [8 ] found predo mma n t chemotactic 
activ ity in t he 14,500 to 18,500-da lton ra nge a nd speculated 
t hat t he 56,000-dalton lympho kin e reported by Cen ter was 
m a de up o f subuni ts o f 14 ,000-da lton facto r. Recent studi es 
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have s uggested that monocytes/macrophages as well as T cells, 
can re lease chemotactic facto rs for T ly mphocytes . Indeed, it 
has been shown t hat highly purified IL-l is a poten t T -cell 
ch emoattractant [9 ,10) . Since t he epidermal cytokin e ETAF 
has m a n y s imila ri t ies to IL- l , we sough t to determine whether 
ETAF could play a role in t he loca lization of T ce lls to skin 
s ites. Because of t he complex ities of in vivo systems, we chose 
to examine t he effect of ETAF on c hemotaxis ofT cells in 
v itro. Us ing a highly purified T -cell population, we found that 
ETAF was a potent T-ce ll chemoattractant. This p roperty 
provides a very sens itive assay fo r ETAF. Moreover, t his find -
ing may have m ajor implications for beni gn a nd neoplastic T-
cell diso rders affecting t he s kin . 
MATERIALS AND METHODS 
Isolation of T -Lymphocyles and Monocyles 
Mononuclea r cells were isolated from peripheral blood drawn from 
normal volunt eers by Hypaque-Ficoll centri fugation and were su -
pended in culture medium (RPM I- 1640, Gibco Laboratories, Grand 
Island, New York) , supplemented with 5% feta l calf serum , 4 mM L-
glutamine and 50 11 g/ ml ge ntamicin ) at a concentration of 5 X 101; ce ll s/ 
mi. The cells were then incubated for 1 h at 37· c in tissue cul ture 
dishes (Cornin g, VWR Scientific, Bell wood, Illinois) to remove adher -
ent cells. The adherent ce lls contain ing 25% viable monocytes as 
assessed by peroxidase sta ining were then used fo r monocyte chemo-
taxi ~. This adherent population co ntai ning 25% monocyt.es had a 97% 
viability as assessed by trypan blue. No nadherent cells we re removed 
by repeated washing of the culture dishes and adherent cells were 
sc raped off the dish with the aid of a rubber policeman. Following 
incubation, the nonadherent cells were washed once with cul ture me-
dium , resuspended in culture medium , and placed on a nylon colu mn 
for 30 min at 37 ' C. Nonadherent cells were elut ed from the column 
with culture medium. was hed twice, and count ed. The resulting ce ll 
popula tion was grea ter than 99% lymphocytes, as assessed by mor-
phology using Wright.-Giemsa sta ins and peroxidase sta ins of the 
monocytes [11 ,12]. The ce ll s were also greater tha n 98";, viabie T 
lymphocytes, as determined by their abi li ty to rosette with neuramin -
idase -treated sheep eryt hrocytes [ !1 ,12]. The purified T cells were then 
incubated in cul ture medium (5 X 106/ ml) with 5 11Ci/ ml of ["H[uridine 
( ew Engla nd Nuclea r, Boston, Massachusetts). After 18 h in culture. 
the ce ll s were washed (X 4) and suspended at4 x 106 viable cell s/ ml in 
cult ure medium for use in the chemotaxis assay. 
T -Lymphocyte Migration 
T -lymph ocyte migration wa measured using blindwell chambers 
{Neuroprobe, Cabin .J ohn , Maryland) in the following ma nne r: the 
bott om well was loaded with 140 11l of either cul ture medium (co ntrol) 
or se ria l di lutions of purified ETAF {in t he same cultu re medium) . Th e 
medium alone or ETAF was separated from 200 11! of I"H]urictine-
labeled T lymphocytes by 2 filters: a thick lower nitroce llu lose filter (5 
11111 pore size; Nuc leopo re, Pleasa nton. California) and a thi n upper 
polycarbonate fi lter (8 11 m pore size; Nucleopore). The chambe rs were 
incubated fo r 4 h a t 37'C in a 5% C0 2 atmosp here. After incubat ion. 
the cells in the upper chambe r as well as the upper fil te r we re disca rded 
and the lower fil te r was washed ge ntly with culture medium and a llowed 
to dry. The dried fi lter was then added to 10 ml of Ready-Solv HP 
Scintillation cockta il (Beckma n Instruments, St.. Louis, Missouri) and 
counted in a liquid scintilla t ion counter (Model LS6800, Beckman 
Instruments). All assays were done in triplicate. Cell migratio n was 
expressed as dpm per experi mental group - dpm pe r control group 
(medium ). Each aliquot of T cells used in the chemotaxis assay was 
labeled wit h app roximately 56,000 dpm of [' Hiuridine. A mean of 5% 
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of the tota l dpm was spontaneously released during the 4-h assay. 
Incubation of the T ce lls wi t h various dilut ions of ETAF (10- 1 to 10-9 ) 
for 4 h did not increase spontaneous release of ["H ]uridine from t he 
ce lls. Incubation of the chemotaxis filters wi th a range of concentration 
of free I"H]uridine as well as supernatan ts of the labeled T cells for 4 
h demonstrated that less than 10% of t he dpm present in the fil te rs 
was due to exposure to free !"H]uridine. In order to distinguish random 
migration (chemokinesis) from directed migration (chemotax is), a 
checkerboard analys is was performed us ing dilu tions of ETAF as 
described hy Zigmond and Hirsch [13]. 
Preparation of ETA F/ IL- 1 
ETAF was prepared from normal hum an epidermal cells as previ-
ously desc ribed [3 [. Brief1 y, human epidermal cells were obtained from 
keratomed sections of whole skin by treatment wit h t rypsin and cul -
tured in DMEM conta inin g 5% fetal calf serum wit hout any addit ional 
stimulants . The medium designated in t his manuscrip t as crude ETAF 
was collected afte r 5 days. Crude ET AF was dialyzed for 24 h aga inst 
phosphate-buffered saline (P BS) in order to remove low-molecular-
weight inhibitory activi t ies. T o obtain ETAF wi th higher specific 
activi ty, crude ETAF was concentrated 20-fold by ultrafil t ration, using 
an Amicon ul t rafil t ration uni t equipped wi th a YM -10 fil te r. The 
concentrate was then passed over a Sephadex G-100 column using PBS 
as eluant. The fractions eluted from the column in the region corre-
sponding to molecular weights between 12,000- 18,000 daltons (mean, 
15,000 daltons) were pooled and designated as column-purified ETAF. 
Monocyte Chemotaxis 
Monocyte chemotaxis was also evaluated using blindwell chambers 
and a single polycarbonate filter (5 I-'m pore size) [1 2]. Blood mono-
nuclea r cells (approxi mately 25% monocytes) were used as target ce ll s. 
Viability was greater than 97% as assessed by t rypa n blue. Chambers 
were incubated for 90 min at 37oC in 5% CO,. After incubation the 
filters were washed and the monocytes were stained with a peroxidase 
stain . At least 5 random fi elds were assessed and the total number of 
monocytes per high-power fi eld that migrated t hrough the filters (ex-
perimenta l group- cont rol group) were counted. 
E.TAFjll, -1 Assay 
ETAF/ lL-1 was assayed using the t hymocyte costimulator assay as 
previously described 13]. 
RESULTS 
These studies revealed tha t both crude a nd partia lly purified 
ETAF were potent T -cell chemoattractants (Fig la,b). A bi-
moda l distribut ion of chemotactic activi ty was routinely seen . 
The first peaks of activity were found at 10-3 dilution for crude 
a nd at 10-~ dilution fo r column purified ETAF. The second 
peaks of activity were found at a 10- •; and 10- 7 dilution, respec-
t ively, fo r c rude a nd purified ETAF. As also seen in Fig 1, 
maximal activi ty in t he thymocyte costimulator assay was 
rout in ely detected a t 10- 1 dilu t ion , and no appreciable activity 
was detected al dilu t ions > 10- r'. In marked contrast to the 
thymocyte costimulator assay, maximal chemotactic activity 
was usually detected over a wide ra nge of dilutions, wi t h peak 
activity see n at 10-H and 10- 7 for crude a nd Sephadex-purified , 
respective ly. At concentra tions > 10- 2 dilu t ion of the factor, 
ETAF rout inely inact ivated lymphocytes in t he chemota xis 
assay. 
Checkerboa rd analysis revealed t h at ETAF was a true chem -
otactic facto r for blood T cells but only a minimal ch emokinetic 
facto r (T able 1). Over a ra nge of dilu t ions , greate r T -cell mi -
gra tion occurred when T cell s were exposed to t he factor in the 
presence of a gradien t (ETAF was present only below t he 
chemotaxis filters) , as compared to exposure of t he cells in the 
absence of a gradi ent (ETAF was present in equal concentra-
t ions above a nd be low t he chemotax is fil te rs ). Monocyte chem -
otax is was assessed using blindwell chambers and a single 
polycarbonate fil te r. As shown in Fig 2a ,b, both crude and 
part ia lly purified ETAF had chemotactic activity . In cont rast 
to T -cell chemotac tic activi ty whic h was detected a t dilu t ions 
of 10- 7 , no appreciable monocyte chemotactic activity was 
detected at dilutions > 10- r'. 
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FI G I. Dilution curves for chemotactic activity (solid line ) and t hy-
mocyte proliferative activity (E TA F/ JL- 1) (dotted line ) of crude ETAF 
and Sephadex G-100 purifi ed ETAF are shown in (a) and (b) , respec-
tively. Error bars indicate mean ± SEM. 
TABLE 1. Checkerboard analys is ofT-cell chemotaxis 
Location of 
stimulus 
Lower chamber 
Both sides 
Upper 
Peak 1" 
(mean dpm 
{"H luridine) 
572 ± 181 
0 ± 64 
78 ± 40 
Peak 2' 
(mean dpm 
{"H]uridine) 
724 ± 191 
108 ± 84 
144 ± 94 
Column-purified ETAF was assayed for chemokinesis vs chemotaxis 
using a checkerboard analysis. Column-purified ETAF was placed in 
the lower chamber of the blindwell chamber, both sides, or t he upper 
chamber. Chemotaxis was then assayed as before. 
• Peak 1 indicates the ftrst peak seen in the dilu tion curve for 
chemotaxis (see Fig 2) using column-purified ETAF. This occurred at 
a 1 o-• dilution. 
b Peak 2 represents column-purified ETAF assayed for chemotaxis 
at a 10- 7 dilut ion. 
DISCUSSION 
The present study demonstrates that ETAF is a poten t 
chemoattractant for no rma l blood T cells. This activity was 
shown in both crude a nd partia lly purif1ed prepa ra tions of 
ETAF. ETAF was shown to be more active as a chemotactic 
facto r for blood T cells compared to blood monocytes. Prior 
studies have also shown that ET AF can fun ction as a chemo-
tac tic factor for neut rophils [14]. In those studies, t he chem o-
tactic activi ty of ETAF for neutrophils para lle led its abili ty to 
augment thymocyte proliferation. In t his study, ETAF func-
tions as a chemoattractant for blood T cells at much lower 
concentrations than t h e concentrat ions required to augm ent 
lectin-induced t hymocyte prolife ration. Chec kerboard an alys is 
revealed that ETAF func t ions primarily as a chemotactic factor 
(increases directed migra tion) for T cells a nd not as a chemo-
kinetic factor (inc reases ra ndom migration) fo r T cells . 
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F IG 2. Capacity of ETAF to act as a monocyte chemoattractant 
(solid line) is quantitated by coun t ing Wright-G iesma stai ned mono-
cytes usi ng a modified Boyden chamber. Figure represents chemotaxis 
di lu t ion curve for crude ETAF (a) and Sep hadex G-100 purified ETAF 
(b) . At least 5 random fields were assessed and t he mean tota l number 
of cells per high-power fi eld (H PF) was calculated. Thymocyte pro li f-
eration activity (ETAF/JL-1) is shown fo r both crude and column 
pu rified ETAF (dotted line ). E rror bars represe nt mean± SEM. 
As shown in Fig 1, chemotactic activity routinely yielded a 
bimodal distribution. The exact reason for th is bimodal distri-
bution is not clear; however, the chemotactic activity of highly 
purified IL-l a lso shows a bimodal distribu_t ion forT cells with 
IL-l, t he bimodal distribution is not explamed by t he capacity 
of one peak of activi ty to attract one ce ll type wh ile t he other 
attracts another cell type; both peaks preferentially attract 
helper T cells. In addi t ion , IL-l can be separated into fractions 
with different isoelectric points; each of t hese highly purified 
forms of IL-l also exhibi t a bimodal pattern of chemotactic 
activity for T cells. In addit ion, a recombinant DNA-derived 
IL-l also exhibi ts a bimodal pattern of chemotactic activi ty for 
T cells. Thus th is bimodal pattern may be a unique feature of 
migrating T cells to a variety of cytokines. These observations 
suggest that epidermal cells possess a powerful mechanism by 
which they can enhance t heir interactio n with circulating T 
ce lls. This could lead to en hanced physical interactions between 
epidermal Langerhans cells and T cells and t hus support prior 
studies which suggest t hat lymphocyte activatio n might be a 
local phenomenon which would not be ini tiated until t he lym-
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phocyte is drawn close to t he vicinity of the epidermal cells 
where the concentrations of ETAF / IL-l would, presumably, be 
higher. This phenomenon might help restrict lymphocyte act i-
vation to actual sites of immune responses. 
Support for t he above hypothesis comes from the observation 
of Laroche eta! [15], who showed that unstimulated peripheral 
blood lymphocytes from patients with Sezary syndrome (a 
cutaneous T -cell lymphoma) include a subpopulation of lym-
phocytes t hat selectively migrate in vitro to sk in fragments. 
They speculated t hat skin explants act as an attracting tissue 
and produce chemotactic substances. Preliminary studies from 
our laboratory indicate that skin explants from pat ients with 
cutaneous T-celllymphoma produce high levels ofETAF (Choi 
and Sauder, unpublished data) . It is possible t hat increased 
levels of ETAF in these patients may provide an inductive 
microenvironment for t he localization of T cells to skin sites. 
In vitro studies are currently under way to assess the response 
of Sezary lymphocytes to t he chemotactic effects of ETAF. 
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